POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $507,474 | +68.6% | 76,083 | +129.0% | 0.00% | – |
Q2 2023 | $300,982 | -63.1% | 33,221 | -70.4% | 0.00% | – |
Q1 2023 | $815,520 | +340.6% | 112,176 | +341.8% | 0.00% | – |
Q4 2022 | $185,108 | -62.7% | 25,392 | -60.4% | 0.00% | – |
Q3 2022 | $496,000 | -24.7% | 64,131 | -33.7% | 0.00% | – |
Q2 2022 | $659,000 | -80.9% | 96,745 | -77.7% | 0.00% | -100.0% |
Q1 2022 | $3,459,000 | – | 434,001 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |